Web31 gen 2024 · 15. Kanemitsu Y, Shitara K, Mizusawa J, Hamaguchi T, Shida D, Komori K, et al. Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial. J Clin Oncol (2024) … Web17 mag 2024 · Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial. J Clin Oncol 2024;39:1098-107. van der Kruijssen DEW, Elias SG, Vink GR, et al.
A randomized controlled trial comparing primary tumour …
Web21 giu 2024 · Kanemitsu Y, Shitara K, Mizusawa J et al (2024) A randomized phase III trial comparing primary tumor resection plus chemotherapy with chemotherapy alone in incurable stage IV colorectal cancer: JCOG1007 study (iPACS). J Clin Oncol 38(4 suppl):7–7. Article Google Scholar Webincurable stage IV colorectal cancer: JCOG1007 (iPACS study). Jpn J Clin Oncol 2024;50:89-93. 13. Kim CW, Baek JH, Choi GS, Yu CS, Kang SB, Park WC, et al. The role of primary tumor resection in colorectal cancer patients with asymptomatic, synchronous unresectable metastasis: study proto-col for a randomized controlled trial. Trials … proftech phone number
Primary Tumor Resection Plus Chemotherapy Versus …
Web9 feb 2024 · iPACS was an open-label, randomized, phase III trial conducted by the Japan Clinical Oncology Group (JCOG; JCOG1007).16 The study Protocol (online only) was ap … WebJCOG1007: Japan: UMIN000008147: 0S, 3 yrs: 770 → 280: Jun 12: Dec 20: Recruiting * SYNCHRONOUS and CCRe-IV trails are ongoing and participants are receiving an … Web12 lug 2024 · JCOG1007, iPACS (Japan) 2024 Stage IV CRC, 3 or less unresectable factors ST alone (mFOLFOX6/CapeOX+BEV) PTR followed by ST … proftech supplies